Nonstructural protein 3 (NS3) of Hepatitis C virus (HCV) is a multifunctional protein and possesses protease, nucleotide triphosphatase and helicase activities. The N-terminal domain of NS3 (amino acids 1027-1218; ANS3) has a trypsin-like protease activity and is essential for processing of viral polyprotein. Accordingly it is a potential target for anti-HCV drugs and we isolated RNA aptamers (Kd = 10 nM, Kj = 100 nM) using in vitro selection strategy. To study the interaction between ANS3 and its aptamer, we applied alanine scanning mutagenesis and constructed seven mutant proteins at positive amino acid residues on the surface of ANS3. Binding and inhibitory activities of the NS3 aptamer against mutant proteins were kinetically analyzed. These results clarified that especially Argl61 and Argl30 are important for interaction with the NS3 aptamer.
INTRODUCTION
Hepatitis C vims (HCV) is a single-stranded RNA virus (9.5 kb in length) and its genome is translated into a single large polyprotein. NS3 protease domain (amino acids 1027-1218; ANS3) located in the N-terminal onethird of nonstructural protein 3 of HCV is essential for processing of the polyprotein during replication of HCV. The tertiary structure of NS3 protease domain was determined by X-ray crystallography and clarified that this NS3 protease folds as a trypsin-like two 6-barrels and has a catalytic triad of His57, Asp81 and Serl39 (1, 2; Fig. 1 ). Using in vitro selection strategy, we selected RNA aptamers that bind specifically to ANS3 (3). These RNA aptamers appeared to be noncompetitive inhibitors against NS3 protease and their inhibitory constants (Ki) were about 100 nM in the presence of NS4A.
Until recently several aptamers for trypsin-like serine proteases have been isolated. Thrombin aptamer is the first example and 3D complex of thrombin and aptamer was determined by X-ray crystallography (4) . Thrombin aptamer binds to the anion binding exosite that is one of the positively charged region and known as fibrinogen binding site. Recently we found that an aptamer for activated protein C (APC) (5) binds to a Lys cluster of APC.
To characterize the interaction between NS3 protease and its aptamer, we investigated the aptamer binding site of protein by alanine-scanning mutagenesis. NS3 protease has mainly three patches of positive amino acid residues on the surface. Cluster I (Arg24, Lys26 and Lys68) is located in the first 6-barrel (amino acids 1-89). Cluster H (Argll7, 118,119, and 123) and cluster m (Argl30, Argl61, and Lysl65) are located in the second 6-barrel (amino acids 101-190) of NS3 protease. We constructed seven kinds of mutant protein (R24A, R24A/K26A, R119A, R130A, R161A, K165A, and R130A/R161A/K165A) by in vitro mutagenesis. Binding and protease inhibition activities of the aptamer against mutant proteins were examined. For kinetic analysis, interaction between the aptamer and mutant proteins were also determined using a biosensor biotin-(dT)l8 oligomer was bound to the surface of streptavidin-coated sensor chip and RNA aptamer was immobilized by hybridization between the 3'-poly(A) tail and the surface-bound oligo(dT) 18 on the sensor chip. ANS3 or its mutant proteins in solution was passed on the aptamer immobilized surface under the certain conditions. The biomolecules interaction on the sensor surface was detected and quantified. Kinetic analysis of interaction between mutant proteins of ANS3 and RNA aptamer was performed using the BIAevalution 3.1 software. R24A, R24A/K26A and R119A focused on cluster I and II showed a no crucial differences with wild-type ANS3 in their kinetic parameters. On the other hand, mutant proteins on cluster HI, especially R161A, R130A and R130A/R161A/K165A, showed high Kd values and difference from wild-type ANS3. This result indicates that the arginine residues at 161 and 130 of cluster HI are important for binding. Further analysis revealed the stoichiometry of interaction between ANS3 and aptamer is approximately 1:1. The aptamer/ANS3 binding was influenced by the presence of Ca^+ ions but not Mg2+ ions.
Analysis of inhibitory effect by aptamer through protease inhibition assay
The inhibiton of protease activity by aptamer were examined and compared through protease inhibition assay. Dansyl labeled-17mer peptide SI was used as a substrate and cleavage assay was carried out in the presence of cofactor P41 (7). All mutant proteins possessed the same level of protease activity. The molar ratio of aptamer/protein in this assay was 0.5,1,2,4,10 and 20, and IC50 value against each protein was calculated.
A representative result is summarized in Table  1 . The activities of ANS3 and 3 mutant proteins, R24A, R24A/K26A, and R119A were blocked 90% at a low concentration of the aptamer (molar ratio <2). IC50 values were low (<0.5 \iM). In the case of other 4 mutant proteins on cluster m, R130A, R161A, K165A and R130A/R161A/K165A, excess amount of aptamer was required for inhibition. Especially, IC50 values of R161A and R130A/R161A/K165A were >20 |iM, and this is 40-fold higher than that of ANS3. Also, IC50 values of R130A and K165A is 3 \M and 1.5 uM, this is 6-fold and 3-fold higher than that of ANS3, respectively. This result suggests that the RNA aptamer binds specifically to cluster IE.
The cluster HI of positive amino acid residues, especially Argl61 and Argl30, on the surface of NS3 protease is important for interaction with NS3 aptamer. It seems similar binding mechanism as thrombin and activated protein C (APC) aptamers. In addition to our previous finding that ANS3 aptamer acts in noncompetitive inhibition (3), the present result suggests that the RNA aptamer binds to this region and changes the conformation of NS3 protease.
